contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-presentation-of-meds-2025-year-end-report-on-february-10-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Meds Apotek is a full-scale e-commerce pharmacy operating in the Swedish outpatient market. The company offers its customers an extensive product range consisting of prescription drugs, over-the-counter drugs and a wide selection of merchandise such as beauty products, dietary supplements, children's products, fitness products, food and beverages and home & household products. Meds Apotek was founded in 2017 and is headquartered in Stockholm.

Meds Apotek

MEDS will publish its 2025 year-end report on February 10, 2026, at 07:30 CET. A webcast presentation will be held for analysts, media, and investors at 09:30 CET the same day.The report will...

<div class="mfn-preamble">MEDS will publish its 2025 year-end report on February 10, 2026, at 07:30 CET. A webcast presentation will be held for analysts, media, and investors at 09:30 CET the same day.</div><div class="mfn-body">The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.The presentation will be conducted in English and broadcast live online. Please email <a rel="noopener" href="mailto:ir@meds.se">ir@meds.se</a>&nbsp; to receive a link to the live presentation (at latest 09:00 CET on 10th of February).A recorded version of the presentation will be available later at:&nbsp;<a rel="noopener" href="https://corporate.meds.se/finansiell-information/rapporter-och-presentationer/">Rapporter och presentationer | MEDS Investor Relations</a> &nbsp; Schedule for the 10th of February:<ul><li>07:30 CET – Publication of the Q4 report</li><li>9:30 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola</li></ul>&nbsp; For further information, please contact: Frida Benno Hjerpe MEDS Press &amp; Investor Relations E-mail:&nbsp;<a rel="noopener" href="mailto:press@meds.se">press@meds.se</a> Web:&nbsp;<a rel="noopener" href="https://corporate.meds.se/">https://corporate.meds.se/</a>About MEDS MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets. In addition, MEDS offers a wide range of products in health, beauty, and wellness.Certified advisor is FNCA.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="noopener" href="https://storage.mfn.se/8c974868-8dd3-4e33-bdea-9c71d8bb345b/invitation-to-presentation-of-meds-2025-year-end-report-on-february-10-2026.pdf" class="mfn-generated mfn-primary">Invitation to presentation of MEDS 2025 year-end report on February 10, 2026</a></div>